期刊文献+

6-取代-吡啶并[3,2-e][1,2,4]三唑并[4,3-a]吡嗪类衍生物的合成及抗惊厥活性研究 被引量:2

Synthesis and Anticonvulsant Activity Evaluation of 6-Substitutedpyrido[3,2-e][1,2,4]triazolo[4,3-a]pyrazine Derivatives
原文传递
导出
摘要 设计合成了一系列6-取代-吡啶并[3,2-e][1,2,4]三唑并[4,3-α]吡嗪类衍生物,分别采用最大电惊厥法(MES)和旋转棒法测定其对小鼠的抗惊厥活性及神经毒性.其化学结构均经过~1H NMR、^(13)C NMR、MS和HRMS进行确征.实验结果显示,6-苯氧基-吡啶并[3,2-e][1,2,4]三唑并[4,3-a]吡嗪(5g)的半数有效剂量(ED_(50))为93.9 mg·kg^(-1),保护指数为24.3,其安全性高于对照药卡马西平,是一种潜在的抗癫痫候选化合物. In this paper, a series of 6-substituted-pyrido[3,2-e] [1,2,4]triazolo[4,3-a]pyrazine derivatives have been synthesized. Their anticonvulsant activity and neurotoxicity in mice were evaluated by maximal electroshock (MES) and rotarod test, respectively. The structures were confirmed by 1H NMR, 13C NMR, MS and HRMS. The experimental results show that 6-phenoxypyrido[3,2-e] [1,2,4]triazolo[4,3-a]pyrazine (5g) was safer than the reference drug, carbamazepine, with ED50value of 93.9 mg·kg^-1 and protective index (PI) value of 24.3, which was a potential anti-epilepsy candidate compound.
作者 李佳丽 胡涛 张洪健 宫国华 全哲山 Li Jiali;Hu Tao;Zhang Hongjian;Gong Guohua;Quan Zhe-Shan(College of Pharmacy,Yanbian University,Yanji 133002;Inner Mongolia Autonomous Region Key laboratory of Mongolian Medicine Pharmacology for Cardio-cerebral Vascular System,Tongliao 028000;Affiliated Hospital of Inner Mongolia University for Nationalities,Tongliao 028000)
出处 《有机化学》 SCIE CAS CSCD 北大核心 2018年第7期1673-1679,共7页 Chinese Journal of Organic Chemistry
基金 国家自然科学基金(Nos.21662036 81660837)资助项目~~
关键词 酞吡啶并[2 3-b]吡嗪 三唑 合成 抗惊厥 最大电惊厥法 pyrido[2,3-b]pyrazine triazole synthesis anticonvulsant the maximal electroshock
  • 相关文献

参考文献3

二级参考文献32

  • 1Gubeman AH, Besag FM, Brode M J, et al. Lamotngine-associated rash: risk/benefit considerations in adults and children. Epilepsia, 1999,40(7) :985-991.
  • 2Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. Epilepsia, 1998,39 ( Suppl 7 ) :S3-7.
  • 3Roujean JC, Stern RS. Severe adverse cutaneous reactions to drugs. Neurol Med, 1994,331(19) :1272-1285.
  • 4Tan H, Gurbuz T, Dagsuyu IM. Gingival enlargement in children treated with antiepileptics. J Child Neurol, 2004,19(12) :958-963.
  • 5Verma SP, Yunis N, Lekos, et al. Carbamazepine induced systemic lupus erythematosus presenting as cardiac tamponade. Chest, 2000,117(2) :597-589.
  • 6Cuturic M, Abramson RK. Acute hyperannnonemic coma with chronic valproic acid therapy. Ann Pharmacother.2005,39 (12) :2119-2123.
  • 7Rath A, Naryanan TJ, Chowdhary GV, et al. Valproate-induced hyperammonemic encephalopathy with normal liver function. Neurol India, 2005,53 (2) :226-228.
  • 8Otusbo S, Huruzono T, Kobae H, et al. Pancreatitis with normal serum amylase associated with sodium valproate: a case report. Brain Dev, 1995,17(3) :219-221.
  • 9Go T. Effect of antiepileptic drug polytherapy on crystalluria. Pediatr Neurol, 2005,32 (2) : 113-115.
  • 10Blackburn SC, Oliart AD, Garcia Rodriguez LA, et al. Anti epileptics and blood dyscrasias: a cohort study. Pharmacotherapy, 1998,18 (6) : 1277-1283.

共引文献34

同被引文献3

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部